“Belimumab in Lupus Nephritis Patients With Impaired Renal Function: A Post-Hoc Analysis of the Bliss-LN Trial”. 2025. Epidemiology, Biostatistics, and Public Health, September. https://doi.org/10.54103/2282-0930/29538.